Literature DB >> 9766964

A pleiotropic model of phenotypic evolution.

Y Tanaka1.   

Abstract

A pleiotropic model is presented for deriving the equilibrium genetic variance by mutation and stabilizing selection and the long-term genetic responses to directional selection in the case where mutations have pleiotropic effects on fitness itself (direct deleterious effect) and on a quantitative trait (phenotypic effect). The equilibrium genetic variance is derived as a general form of the rare-alleles models, i.e., [formula: see text], where n is the number of loci, mu is the per-locus mutation rate, alpha 2 is the variance of new mutations, V(s) is the measure of stabilizing selection, and s(u) is the selection coefficient on mutations by direct deleterious effect. The genetic responses to directional selection is calculated based on the assumption that the genetic variance is kept at an equilibrium by mutation and stabilizing selection but without directional selection, and the directional selection starts to operate on the target trait. The evolutionary rate at the t-th generation after the introduction of the directional selection is [formula: see text], where i is the directional selection intensity, and s(T) is the total selection coefficient on mutations, i.e., [formula: see text]. The selection limit is [formula: see text], where V(m) is the mutational variance (2n mu alpha 2). The pleiotropic effects of genes reduce both the evolutionary rate and the selection limit.

Mesh:

Substances:

Year:  1998        PMID: 9766964

Source DB:  PubMed          Journal:  Genetica        ISSN: 0016-6707            Impact factor:   1.082


  2 in total

1.  Joint effects of pleiotropic selection and stabilizing selection on the maintenance of quantitative genetic variation at mutation-selection balance.

Authors:  Xu-Sheng Zhang; William G Hill
Journal:  Genetics       Date:  2002-09       Impact factor: 4.562

2.  Apparent directional selection by biased pleiotropic mutation.

Authors:  Yoshinari Tanaka
Journal:  Genetica       Date:  2010-03-14       Impact factor: 1.082

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.